{"id":"W2776194348","doi":"10.1093/annonc/mdx820","title":"CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Osimertinib; Internal medicine; T790M; Oncology; Ceritinib; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Clinical trial; Lung cancer; Cancer; Epidermal growth factor receptor; Erlotinib; Crizotinib; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01738959,0.001729592,0.005592425,0.001162897,0.000296645,0.001631279,0.0006714426,0.00114826,0.001393944],"category_scores_gemma":[0.01388598,0.0006036095,0.01073417,0.001770396,0.0005133,0.001065231,0.0007923688,0.001232347,0.0002471716],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009321732,"about_ca_system_score_gemma":0.001093992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006742339,"about_ca_topic_score_gemma":0.002444089,"domain_scores_codex":[0.9926852,0.004207716,0.001329326,0.0007449179,0.0007607549,0.0002720441],"domain_scores_gemma":[0.9916694,0.003494561,0.002924399,0.0008176771,0.0006739512,0.0004199899],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5122326,0.0009466145,0.05386607,0.01213647,0.3260659,0.0001794233,0.0002419951,0.003308854,0.006125445,0.000124102,0.002978199,0.08179434],"study_design_scores_gemma":[0.2202661,0.06854454,0.2390713,0.001995219,0.453535,0.0007649728,0.0002179895,0.002017316,0.003044311,0.000699265,0.00965011,0.0001938262],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8225282,0.1586908,0.002572141,0.0008613245,0.000357926,0.00298858,0.008087438,0.0001487111,0.003764956],"genre_scores_gemma":[0.976557,0.0151196,0.0008780684,0.0006248709,0.0003045639,0.001265139,0.004764144,0.00003946941,0.0004471575],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01738959,"threshold_uncertainty_score":0.09196609,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1298384621559635,"score_gpt":0.5199645404744228,"score_spread":0.3901260783184592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}